Prakash Deedwania, MD
Professor of Clinical Medicine
Cardiology - Fresno
School of Medicine

Publications (404)

Top publication keywords:
Myocardial IschemiaCholesterol, LDLHeart FailureHydroxymethylglutaryl-CoA Reductase InhibitorsMetabolic SyndromeCoronary DiseaseAnticholesteremic AgentsAdrenergic beta-AntagonistsDiabetic AngiopathiesHeptanoic AcidsAngina PectorisHypertensionAngiotensin-Converting Enzyme InhibitorsCardiovascular DiseasesDiabetes Mellitus, Type 2

• Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial.
  Diabetes care 2025 Kang YM, Giugliano RP, Ran X, Deedwania P, De Ferrari GM, George JT, Gouni-Berthold I, Paiva da Silva Lima G, Handelsman Y, Lewis BS, Ohman EM, Wang H, López JAG, Monsalvo ML, Sabatine MS, Leiter LA
• Higher Risk of Kidney Failure Associated With Angiotensin Receptor Blockers vs ACE Inhibitors in Patients With Heart Failure.
  The American journal of medicine 2025 Moore HJ, Wu WC, Heidenreich PA, Rossignol P, Patel SS, Lu F, Lam PH, Ahmed AA, Faselis C, Butler J, Palant CE, Pitt B, Weir MR, Deedwania P, Atkins D, Raman VK, Rangaswami J, Vargas JD, Zhang S, …
• Renin Angiotensin Inhibition and Lower Risk of Kidney Failure in Patients with Heart Failure.
  The American journal of medicine 2025 Patel SS, Raman VK, Zhang S, Sheriff HM, Fonarow GC, Heidenreich PA, Faselis C, Lam PH, Morgan CJ, Moore H, Atkins D, Cheng Y, Shao Y, Deedwania P, Palant CE, Sauer BC, Mehta RL, Love TE, Allman RM, …
• Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.
  JACC. Heart failure 2025 Patel S, Raman VK, Faselis C, Fonarow GC, Lam PH, Ahmed AA, Heidenreich PA, Anker SD, Deedwania P, Morgan CJ, Zhang S, Moore H, Rangaswami J, Bakris G, Butler J, Sheriff HM, Allman RM, Zeng-Treitler Q…
• Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure.
  The American journal of medicine 2024 Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A

Show all (399 more) Hide

• Global Community Health Screening and Educational Intervention for Early Detection of Cardiometabolic Renal Disease.
  Annals of global health 2024 Nabaty NL, Menon T, Trang G, Vijay A, Chogyal L, Cataldo R, Govind N, Jain P, Singh P, Dolasa N, Sahani M, Deedwania P, Vijayaraghavan K
• Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure.
  European journal of heart failure 2024 Patel SS, Raman VK, Zhang S, Deedwania P, Zeng-Treitler Q, Wu WC, Lam PH, Bakris G, Moore H, Heidenreich PA, Rangaswami J, Morgan CJ, Cheng Y, Sheriff HM, Faselis C, Mehta RL, Anker SD, Fonarow GC, …
• Considerations Regarding Management of Heart Failure in Older Adults.
  Cardiology in review 2024 Alagiakrishnan K, Mah D, Aronow WS, Lam PH, Frishman WH, Ahmed A, Deedwania P
• Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.
  Journal of clinical lipidology 2024 Puri R, Bansal M, Mehta V, Duell PB, Wong ND, Iyengar SS, Kalra D, Nair DR, Nanda NC, Narula J, Deedwania P, Yusuf J, Dalal JJ, Shetty S, Vijan VM, Agarwala R, Kumar S, Vijay K, Khan A, Wander GS, …
• Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction.
  Drugs 2023 Patel J, Rassekh N, Fonarow GC, Deedwania P, Sheikh FH, Ahmed A, Lam PH
• Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.
  Circulation 2023 Kwan TW, Wong SS, Hong Y, Kanaya AM, Khan SS, Hayman LL, Shah SH, Welty FK, Deedwania PC, Khaliq A, Palaniappan LP, American Heart Association Council on Epidemiology and Prevention; Council on …
• Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
  The American journal of medicine 2023 Patel S, Lam PH, Kanonidis EI, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A
• Imaging modality for left ventricular ejection fraction estimation and effect of implantable cardioverter-defibrillator on mortality in patients with heart failure.
  Heart rhythm 2023 Smith A, Kumar S, Moore HJ, Iskandrian AE, Nanda NC, Raman VK, Singh S, Fletcher RD, Deedwania P, Fonarow GC, Greenberg MD, Ahmed A, Lam PH
• Risk of Stroke in Older Adults With Heart Failure.
  The American journal of cardiology 2022 Bierbower E, Griffith N, Raman VK, Brar V, Roseman J, Deedwania P, Fonarow GC, Allman RM, Faselis C, Zhang S, Howard G, Ahmed A, Lam PH
• Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
  JAMA oncology 2022 Faselis C, Nations JA, Morgan CJ, Antevil J, Roseman JM, Zhang S, Fonarow GC, Sheriff HM, Trachiotis GD, Allman RM, Deedwania P, Zeng-Trietler Q, Taub DD, Ahmed AA, Howard G, Ahmed A
• Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension.
  Progress in cardiovascular diseases 2022 Lam PH, Tsimploulis A, Patel S, Raman VK, Arundel C, Faselis C, Deedwania P, Sheikh FH, Banerjee SK, Allman RM, Fonarow GC, Aronow WS, Ahmed A
• GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice.
  Journal of the American Association of Nurse Practitioners 2022 Coke LA, Deedwania PC, Hinnen D, Magwire M, Miller NH
• Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.
  Circulation 2022 Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, Di Palo KE, Golden SH, Sperling LS, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic …
• In-Hospital Weight Loss and Outcomes in Patients With Heart Failure.
  Journal of cardiac failure 2021 Gill GS, Lam PH, Brar V, Patel S, Arundel C, Deedwania P, Faselis C, Allman RM, Zhang S, Morgan CJ, Fonarow GC, Ahmed A
• Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9.
  Journal of the American College of Cardiology 2021 Joseph JJ, Ortiz R, Acharya T, Golden SH, López L, Deedwania P
• Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction.
  The American journal of medicine 2021 Bayoumi E, Lam PH, Enders R, Arundel C, Sheriff HM, Brar V, Jurgens CY, Deedwania P, Faselis C, Allman RM, Fonarow GC, Ahmed A
• Initiation of Anti-Hypertensive Drugs and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction.
  The American journal of medicine 2021 Lam PH, Aronow WS, Tsimploulis A, Bhyan P, Allam SD, Patel S, Raman VK, Arundel C, Sheikh FH, Kanonidis IE, Deedwania P, Allman RM, Fonarow GC, Faselis C, Ahmed A
• Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.
  Circulation 2021 Kris-Etherton PM, Petersen KS, Després JP, Anderson CAM, Deedwania P, Furie KL, Lear S, Lichtenstein AH, Lobelo F, Morris PB, Sacks FM, Ma J
• SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics.
  American journal of cardiovascular drugs : drugs, devices, and other interventions 2021 Deedwania P
• Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection Fraction.
  Journal of cardiac failure 2021 Lam PH, Keramida K, Filippatos GS, Gupta N, Faselis C, Deedwania P, George B, Iskandrian A, Cleland JG, Choudhary G, Wu WC, Morgan CJ, Fonarow GC, Ahmed A
• Income disparity and incident cardiovascular disease in older Americans.
  Progress in cardiovascular diseases 2021 Faselis C, Safren L, Allman RM, Lam PH, Brar V, Morgan CJ, Ahmed AA, Deedwania P, Alagiakrishnan K, Sheikh FH, Fonarow GC, Ahmed A
• A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.
  The American journal of medicine 2021 Pagidipati NJ, Deedwania P
• Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.
  Circulation journal : official journal of the Japanese Circulation Society 2021 Keech AC, Oyama K, Sever PS, Tang M, Murphy SA, Hirayama A, Lu C, Tay L, Deedwania PC, Siu CW, Lira Pineda A, Choi D, Charng MJ, Amerena J, Wan Ahmad WA, Chopra VK, Pedersen TR, Giugliano RP, Sabatine…
• Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial.
  JAMA cardiology 2021 Deedwania P, Murphy SA, Scheen A, Badariene J, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP
• Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.
  The American journal of medicine 2021 Faselis C, Lam PH, Patel S, Arundel C, Filippatos G, Deedwania P, Zile MR, Wopperer S, Nguyen T, Allman RM, Fonarow GC, Ahmed A
• Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.
  American journal of cardiovascular drugs : drugs, devices, and other interventions 2020 Kaul S, Gupta M, Bandyopadhyay D, Hajra A, Deedwania P, Roddy E, Mamas M, Klein A, Lavie CJ, Fonarow GC, Ghosh RK
• Defining the Role of Icosapent Ethyl in Clinical Practice.
  American journal of cardiovascular drugs : drugs, devices, and other interventions 2020 Chatterjee S, Hajra A, Bandyopadhyay D, Ghosh RK, Deedwania PC
• Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey.
  International Journal of Cardiology. Hypertension 2020 Gupta K, Ramakrishnan S, Zachariah G, Rao JS, Mohanan PP, Venugopal K, Sateesh S, Sethi R, Jain D, Bardolei N, Mani K, Kakar TS, Jain V, Gupta P, Gupta R, Bansal S, Nath RK, Tyagi S, Wander GS, Gupta …
• Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.
  The American journal of medicine 2020 Faselis C, Lam PH, Zile MR, Bhyan P, Tsimploulis A, Arundel C, Patel S, Kokkinos P, Deedwania P, Bhatt DL, Zeng-Trietler Q, Morgan CJ, Aronow WS, Allman RM, Fonarow GC, Ahmed A
• Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials.
  Circulation. Cardiovascular quality and outcomes 2020 Foti K, Foraker RE, Martyn-Nemeth P, Anderson CAM, Cook NR, Lichtenstein AH, de Ferranti SD, Young DR, Hivert MF, Ross R, Deedwania P, Whitsel LP, Appel LJ
• Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
  Journal of the American College of Cardiology 2020 Faselis C, Arundel C, Patel S, Lam PH, Gottlieb SS, Zile MR, Deedwania P, Filippatos G, Sheriff HM, Zeng Q, Morgan CJ, Wopperer S, Nguyen T, Allman RM, Fonarow GC, Ahmed A
• Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
  The American journal of medicine 2020 Singh S, Moore H, Karasik PE, Lam PH, Wopperer S, Arundel C, Tummala L, Anker MS, Faselis C, Deedwania P, Morgan CJ, Zeng Q, Allman RM, Fonarow GC, Ahmed A
• Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
  Circulation 2020 Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, Kosiborod M, Leiter LA, Lipska KJ, Newman JD, Welty FK, American Heart Association Council on Lifestyle and Cardiometabolic …
• Association between depression and readmission of heart failure: A national representative database study.
  Progress in cardiovascular diseases 2020 Patel N, Chakraborty S, Bandyopadhyay D, Amgai B, Hajra A, Atti V, Das A, Ghosh RK, Deedwania PC, Aronow WS, Lavie CJ, Di Tullio MR, Vaduganathan M, Fonarow GC
• Aspirin for Primary Prevention of Coronary Artery Disease.
  Current problems in cardiology 2020 Ujjawal A, Gupta M, Ghosh RK, Jain V, Bandyopadhyay D, Qamar A, Aronow WS, Deedwania P, Kapadia S, Lavie CJ
• Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar.
  Journal of the American College of Cardiology 2019 Dixon DL, Sharma G, Sandesara PB, Yang E, Braun LT, Mensah GA, Sperling LS, Deedwania PC, Virani SS
• Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey.
  Indian heart journal 2019 Ramakrishnan S, Zachariah G, Gupta K, Shivkumar Rao J, Mohanan PP, Venugopal K, Sateesh S, Sethi R, Jain D, Bardolei N, Mani K, Kakar TS, Kidambi B, Bhushan S, Verma SK, Bhargava B, Roy A, Kothari SS,…
• Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure.
  The American journal of cardiology 2019 Ghosh RK, Ghosh GC, Gupta M, Bandyopadhyay D, Akhtar T, Deedwania P, Lavie CJ, Fonarow GC, Aneja A
• Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword.
  Progress in cardiovascular diseases 2019 Deedwania P
• Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014.
  Current problems in cardiology 2019 Bandyopadhyay D, Banerjee U, Hajra A, Chakraborty S, Amgai B, Ghosh RK, Haddadin FI, Modi VA, Sinha K, Aronow WS, Deedwania P, Lavie CJ
• Cardiovascular outcome trials of the newer anti-diabetic medications.
  Progress in cardiovascular diseases 2019 Acharya T, Deedwania P
• An update on pharmacotherapies in diabetic dyslipidemia.
  Progress in cardiovascular diseases 2019 Gupta M, Tummala R, Ghosh RK, Blumenthal C, Philip K, Bandyopadhyay D, Ventura H, Deedwania P
• Oral insulin: an update.
  Minerva endocrinologica 2019 Chatterjee S, Bhushan Sharma C, Lavie CJ, Adhikari A, Deedwania P, O'keefe JH
• Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials.
  Journal of clinical lipidology 2019 Ferdinand KC, Jacobson TA, Koren A, Elassal J, Thompson D, Deedwania P
• Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.
  Journal of the American College of Cardiology 2019 Charytan DM, Sabatine MS, Pedersen TR, Im K, Park JG, Pineda AL, Wasserman SM, Deedwania P, Olsson AG, Sever PS, Keech AC, Giugliano RP, FOURIER Steering Committee and Investigators
• Cardiovascular Protection with Anti-hyperglycemic Agents.
  American journal of cardiovascular drugs : drugs, devices, and other interventions 2019 Deedwania P, Acharya T
• Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America.
  Cardiorenal medicine 2019 Vijayaraghavan K, McCullough PA, Singh B, Gupta M, Enas E, Mohan V, Misra A, Deedwania P, Brinton EA, for the Consensus Panel Steering Committee
• Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies.
  The American journal of medicine 2019 Tummala R, Ghosh RK, Jain V, Devanabanda AR, Bandyopadhyay D, Deedwania P, Aronow WS
• The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease.
  Journal of the American Heart Association 2018 Deedwania P
• Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs.
  Journal of the American College of Cardiology 2018 Deedwania P
• American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.
  Journal of the American Heart Association 2018 Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E
• Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
  The American journal of medicine 2018 Lam PH, Gupta N, Dooley DJ, Singh S, Deedwania P, Zile MR, Bhatt DL, Morgan CJ, Pitt B, Fonarow GC, Ahmed A
• SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?
  Current problems in cardiology 2018 Chatterjee S, Bandyopadhyay D, Ghosh RK, Majumdar U, Aneja A, Lavie CJ, Deedwania P
• Obesity is rarely healthy.
  The lancet. Diabetes & endocrinology 2018 Lavie CJ, Deedwania P, Ortega FB
• Dangers and Long-Term Outcomes in Metabolically Healthy Obesity: The Impact of the Missing Fitness Component.
  Journal of the American College of Cardiology 2018 Deedwania P, Lavie CJ
• Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
  JAMA cardiology 2018 Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, Deedwania P, Butler J, Aronow WS, Yancy CW, Fonarow GC, Ahmed A
• 25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch.
  Indian heart journal 2017 Gupta R, Gupta VP, Prakash H, Agrawal A, Sharma KK, Deedwania PC
• Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.
  Journal of clinical hypertension (Greenwich, Conn.) 2017 Deedwania P, Weber M, Reimitz PE, Bakris G
• Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
  Journal of the American College of Cardiology 2017 Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, Butler J, Mohammed SF, Wu WC, Panjrath G, Zile MR, White M, Arundel C, Love TE, Blackman MR, Allman RM, Aronow WS, Anker SD, Fonarow GC, …
• Hearty Breakfast for Healthier Arteries.
  Journal of the American College of Cardiology 2017 Deedwania P, Acharya T
• Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
  European journal of heart failure 2017 Lam PH, Dooley DJ, Fonarow GC, Butler J, Bhatt DL, Filippatos GS, Deedwania P, Forman DE, White M, Fletcher RD, Arundel C, Blackman MR, Adamopoulos C, Kanonidis IE, Aban IB, Patel K, Aronow WS, Allman…
• Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.
  The lancet. Diabetes & endocrinology 2017 Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, Murphy SA, Kuder JF, Gouni-Berthold I, Lewis BS, Handelsman Y, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR
• Treatment of systolic hypertension and low diastolic blood pressure in older adults: How low is too low?!
  International journal of cardiology 2017 Tsimploulis A, Sheriff HM, Anker MS, Deedwania P, Fletcher RD, Aronow WS, Anker SD, Ahmed A
• Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.
  Journal of the American Medical Directors Association 2017 Sheriff HM, Thogaripally MR, Panjrath G, Arundel C, Zeng Q, Fonarow GC, Butler J, Fletcher RD, Morgan C, Blackman MR, Deedwania P, Love TE, Aronow WS, Anker SD, Allman RM, Ahmed A
• Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16].
  International journal of cardiology 2017 Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, …
• Updated risk factors should be used to predict development of diabetes.
  Journal of diabetes and its complications 2017 Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM, NAVIGATOR Study Group
• Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.
  International journal of cardiology 2017 Sheriff HM, Tsimploulis A, Valentova M, Anker MS, Deedwania P, Banach M, Morgan CJ, Blackman MR, Fonarow GC, White M, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A
• Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
  International journal of cardiology 2017 Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, …
• Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program.
  American heart journal 2017 Deedwania P, Acharya T, Kotak K, Fonarow GC, Cannon CP, Laskey WK, Peacock WF, Pan W, Bhatt DL, GWTG Steering Committee and Investigators
• Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?
  Journal of the American College of Cardiology 2017 Deedwania P, Acharya T
• Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
  International journal of cardiology 2016 Lam PH, Dooley DJ, Inampudi C, Arundel C, Fonarow GC, Butler J, Wu WC, Blackman MR, Anker MS, Deedwania P, White M, Prabhu SD, Morgan CJ, Love TE, Aronow WS, Allman RM, Ahmed A
• Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
  Current hypertension reports 2016 Srikanth S, Deedwania P
• Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
  The American journal of cardiology 2016 Borer JS, Deedwania PC, Kim JB, Böhm M
• Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.
  International journal of cardiology 2016 Deedwania PC, Pedersen TR, DeMicco DA, Breazna A, Betteridge DJ, Hitman GA, Durrington P, Neil A, TNT, CARDS and IDEAL Steering Committees and Investigators
• Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.
  The American journal of medicine 2016 Arundel C, Lam PH, Khosla R, Blackman MR, Fonarow GC, Morgan C, Zeng Q, Fletcher RD, Butler J, Wu WC, Deedwania P, Love TE, White M, Aronow WS, Anker SD, Allman RM, Ahmed A
• Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
  The American journal of medicine 2016 Sanam K, Bhatia V, Bajaj NS, Gaba S, Morgan CJ, Fonarow GC, Butler J, Deedwania P, Prabhu SD, Wu WC, White M, Love TE, Aronow WS, Fletcher RD, Allman RM, Ahmed A
• Mechanical Circulatory Support and Rationale for Future Research-Reply.
  JAMA internal medicine 2016 Deedwania P, Acharya T
• Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).
  The American journal of cardiology 2016 Shepherd J, Breazna A, Deedwania PC, LaRosa JC, Wenger NK, Messig M, Wilson DJ, Treating to New Targets Steering Committee and Investigators
• Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.
  Diabetes, obesity & metabolism 2016 Deedwania PC, Shepherd J, Breazna A, DeMicco DA, Treating to New Targets (TNT) Steering Committee Investigators
• Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.
  Drugs & aging 2015 Deedwania PC, Stone PH, Fayyad RS, Laskey RE, Wilson DJ
• Is Increased Use of Mechanical Circulatory Support Devices Justified? A Cause for Concern.
  JAMA internal medicine 2015 Deedwania P, Acharya T
• The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
  Expert opinion on drug safety 2015 Kiel RG, Deedwania P
• Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.
  The American journal of cardiology 2015 Acharya T, Tringali S, Bhullar M, Nalbandyan M, Ilineni VK, Carbajal E, Deedwania P
• Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.
  Journal of the American College of Cardiology 2015 Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, El-Chami MF, Bhakta S, Winchester DE, Al-Mallah MH, Sanchez Shields M, Deedwania P, Mehta LS, Phan BA, Benowitz NL
• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
  Journal of clinical lipidology 2015 Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, …
• Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
  Diabetes care 2015 Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, …
• Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
  Circulation 2015 Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, …
• Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
  European journal of heart failure 2015 Anker SD, Kosiborod M, Zannad F, Piña IL, McCullough PA, Filippatos G, van der Meer P, Ponikowski P, Rasmussen HS, Lavin PT, Singh B, Yang A, Deedwania P
• Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking.
  Circulation. Heart failure 2015 Ahmed AA, Patel K, Nyaku MA, Kheirbek RE, Bittner V, Fonarow GC, Filippatos GS, Morgan CJ, Aban IB, Mujib M, Desai RV, Allman RM, White M, Deedwania P, Howard G, Bonow RO, Fletcher RD, Aronow WS, …
• Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study.
  Journal of global health 2015 Gupta R, Sharma KK, Gupta BK, Gupta A, Saboo B, Maheshwari A, Mahanta T, Deedwania PC
• Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation.
  The International journal of angiology : official publication of the International College of Angiology, Inc 2015 Aftab W, Gazallo J, Motabar A, Varadrajan P, Deedwania PC, Pai RG
• An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation.
  Core evidence 2015 Acharya T, Deedwania P
• Low Prevalence of AHA-Defined Ideal Cardiovascular Health Factors: A Study of Urban Indian Men and Women.
  Global heart 2015 Gupta B, Gupta R, Sharma KK, Gupta A, Mahanta TG, Deedwania PC
• Gaps in guideline implementation: a cause for concern, time for action.
  Journal of the American College of Cardiology 2015 Deedwania P
• Educational status-related disparities in awareness, treatment and control of cardiovascular risk factors in India.
  Heart Asia 2015 Gupta R, Sharma KK, Gupta BK, Gupta A, Gupta RR, Deedwania PC
• Management of Patients With Stable Angina and Type 2 Diabetes.
  Reviews in cardiovascular medicine 2015 Deedwania PC
• Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
  The American journal of medicine 2014 Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A
• Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers.
  PloS one 2014 Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ, Treating to New Targets (TNT) Investigators
• Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
  Circulation. Heart failure 2014 Jones LG, Sin MK, Hage FG, Kheirbek RE, Morgan CJ, Zile MR, Wu WC, Deedwania P, Fonarow GC, Aronow WS, Prabhu SD, Fletcher RD, Ahmed A, Allman RM
• Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India.
  BMJ open diabetes research & care 2014 Gupta A, Gupta R, Sharma KK, Lodha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Deedwania PC
• Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
  The American journal of medicine 2014 Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Deedwania P, Grau-Sepulveda M, Schwamm LH, Bhatt DL, Get With the Guidelines Steering Committee and Investigators
• Reply: To PMID 24846806.
  The American journal of cardiology 2014 Inampudi C, Deedwania P, Fonarow GC, Sanders PW, Aronow WS, Ahmed A
• Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
  The American journal of medicine 2014 Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS
• Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.
  Circulation. Heart failure 2014 Patel K, Fonarow GC, Ahmed M, Morgan C, Kilgore M, Love TE, Deedwania P, Aronow WS, Anker SD, Ahmed A
• Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction.
  International journal of cardiology 2014 White M, Patel K, Caldentey G, Deedwania P, Kheirbek R, Fletcher RD, Aban IB, Lo A, Aronow WS, Fonarow GC, Anker SD, Ahmed A
• Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults.
  The American journal of cardiology 2014 Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, Fonarow GC, Nanda NC, Prabhu SD, Adamopoulos C, Kheirbek R, Aronow WS, Fletcher RD, Anker SD, Ahmed A, Deedwania P
• High prevalence of metabolic syndrome among urban subjects in India: a multisite study.
  Diabetes & metabolic syndrome 2014 Deedwania PC, Gupta R, Sharma KK, Achari V, Gupta B, Maheshwari A, Gupta A
• Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.).
  The American journal of cardiology 2014 Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Sanders PW, Prabhu SD, Butler J, Forman DE, Aronow WS, Allman RM, Ahmed A
• Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study.
  Indian heart journal 2014 Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V, Sharma KK
• Statins in chronic kidney disease: cardiovascular risk and kidney function.
  Postgraduate medicine 2014 Deedwania PC
• Medical treatment of hypertension in patients with heart failure with preserved ejection fraction.
  Current cardiology reports 2013 Kiel RG, Deedwania P
• Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.
  The American journal of medicine 2013 Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM
• Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
  The American journal of medicine 2013 Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH, Treating to New Targets Steering Committee and Investigators
• Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
  Drugs 2013 Deedwania P
• Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial.
  European heart journal 2013 Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH, Treating to New Targets Steering Committee and Investigators
• Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.
  International journal of cardiology 2013 Deedwania P, Patel K, Fonarow GC, Desai RV, Zhang Y, Feller MA, Ovalle F, Love TE, Aban IB, Mujib M, Ahmed MI, Anker SD, Ahmed A
• A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
  The American journal of cardiology 2013 Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM
• Diabetes, cardiovascular disease, and ethnicity.
  Journal of the American College of Cardiology 2013 Deedwania P
• Primary Prevention of Atrial Fibrillation - The Path Untread.
  Journal of atrial fibrillation 2013 Lardizabal JA, Deedwania PC
• Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.
  Journal of clinical hypertension (Greenwich, Conn.) 2013 Deedwania P, Shea J, Chen W, Brener L
• New oral anticoagulants in elderly patients with atrial fibrillation.
  The American journal of medicine 2013 Deedwania PC
• Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control.
  American journal of hypertension 2013 Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, Mahanta TG, Asirvatham AJ, Gupta S, Maheshwari A, Saboo B, Jali MV, Singh J, Guptha S, Sharma KK
• Ivabradine in heart failure: hope or hype?
  American journal of cardiovascular drugs : drugs, devices, and other interventions 2012 Deedwania PC
• Prediabetes and the risk of diabetes.
  Lancet (London, England) 2012 Deedwania P, Ahmed A
• β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
  JAMA 2012 Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL, REACH Registry Investigators
• Evidence-based therapy for heart failure.
  The Medical clinics of North America 2012 Deedwania PC, Carbajal E
• Heart failure: a common and complex clinical syndrome.
  The Medical clinics of North America 2012 Deedwania PC
• The epidemiology and pathophysiology of heart failure.
  The Medical clinics of North America 2012 Rathi S, Deedwania PC
• Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study.
  PloS one 2012 Gupta R, Deedwania PC, Sharma K, Gupta A, Guptha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Gupta R
• Atrial fibrillation in heart failure.
  The Medical clinics of North America 2012 Lardizabal JA, Deedwania PC
• An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation.
  Core evidence 2012 Deedwania P, Huang GW
• Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?
  Journal of clinical hypertension (Greenwich, Conn.) 2012 Deedwania PC, Zappe DH, Egan BM, Purkayastha D, Samuel R, Sowers JR
• Regional variations in cardiovascular risk factors in India: India heart watch.
  World journal of cardiology 2012 Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P
• Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study.
  Circulation 2012 Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD
• Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).
  The American journal of cardiology 2012 Ho JE, Waters DD, Kean A, Wilson DJ, Demicco DA, Breazna A, Wun CC, Deedwania PC, Khush KK, TNT Investigators
• Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program.
  Circulation. Cardiovascular quality and outcomes 2012 Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL, Get With The Guidelines Steering Committee and Investigators
• An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.
  Reviews in cardiovascular medicine 2012 Deedwania P, Huang GW
• Polymorphisms and noncardioembolic stroke in three case-control studies.
  Cerebrovascular diseases (Basel, Switzerland) 2011 Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C
• The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies.
  Circulation. Cardiovascular genetics 2011 Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ, TNT and IDEAL Investigators
• Twenty-year trends in cardiovascular risk factors in India and influence of educational status.
  European journal of preventive cardiology 2011 Gupta R, Guptha S, Gupta VP, Agrawal A, Gaur K, Deedwania PC
• A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults.
  The American journal of cardiology 2011 Roy B, Pawar PP, Desai RV, Fonarow GC, Mujib M, Zhang Y, Feller MA, Ovalle F, Aban IB, Love TE, Iskandrian AE, Deedwania P, Ahmed A
• ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes.
  Annals of internal medicine 2011 Deedwania P
• Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
  The American journal of medicine 2011 Deedwania PC, Carbajal EV
• Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease.
  The American journal of cardiology 2011 Guey LT, Pullinger CR, Ishida BY, O'Connor PM, Zellner C, Francone OL, Laramie JM, Naya-Vigne JM, Siradze KA, Deedwania P, Redberg RF, Frost PH, Seymour AB, Kane JP, Malloy MJ
• Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
  American journal of cardiovascular drugs : drugs, devices, and other interventions 2011 Deedwania PC, Huang GW
• Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.
  International journal of cardiology 2011 Desai RV, Guichard JL, Mujib M, Ahmed MI, Feller MA, Fonarow GC, Meyer P, Iskandrian AE, Bogaard HJ, White M, Aban IB, Aronow WS, Deedwania P, Waagstein F, Ahmed A
• Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?
  Circulation 2011 Deedwania PC
• Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.
  International journal of cardiology 2011 Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, Lainscak M, Aban I, White M, Aronow WS, Deedwania P, Iskandrian AE, Ahmed A
• Endothelium-dependent vasodilation is impaired in healthy offspring of hypertensive parents.
  Indian heart journal 2011 Bharani A, Jain N, Jain A, Deedwania P
• Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure.
  European journal of heart failure 2011 Deedwania PC, Ahmed MI, Feller MA, Aban IB, Love TE, Pitt B, Ahmed A
• Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.
  Current medical research and opinion 2011 Fonseca V, Sharma PP, Shah M, Deedwania P
• Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.
  The American journal of cardiology 2011 Banach M, Bhatia V, Feller MA, Mujib M, Desai RV, Ahmed MI, Guichard JL, Aban I, Love TE, Aronow WS, White M, Deedwania P, Fonarow G, Ahmed A
• Interventions for cardiovascular disease prevention.
  Cardiology clinics 2011 Gupta R, Deedwania P
• Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
  Cardiology clinics 2011 Lardizabal JA, Deedwania P
• Preface cardiovascular disease prevention: the continuum of primary and secondary prevention.
  Cardiology clinics 2011 Deedwania P
• Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus.
  Cardiology clinics 2011 Srikanth S, Deedwania P
• Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention.
  Cardiology clinics 2011 Vijayaraghavan K, Deedwania P
• Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease.
  Cardiology clinics 2011 Carbajal EV, Deedwania P
• The anti-ischemic and anti-anginal properties of statins.
  Current atherosclerosis reports 2011 Lardizabal JA, Deedwania PC
• Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG).
  American heart journal 2011 Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez A, Peterson ED, Fonarow GC
• Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study.
  Annals of medicine 2011 Mujib M, Desai RV, Ahmed MI, Guichard JL, Feller MA, Ekundayo OJ, Deedwania P, Ali M, Aban IB, Love TE, White M, Aronow WS, Rahimtoola SH, Bonow RO, Ahmed A
• Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
  Journal of the American College of Cardiology 2011 Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ, TNT Study Investigators
• Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.
  The American journal of cardiology 2010 Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A
• Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG).
  American heart journal 2010 Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez AF, Peterson ED, Fonarow GC
• Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers.
  Journal of clinical hypertension (Greenwich, Conn.) 2010 Deedwania P
• The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus.
  Current cardiology reports 2010 Lardizabal JA, Deedwania PC
• Low high-density lipoprotein cholesterol: current status and future strategies for management.
  Vascular health and risk management 2010 Singh V, Sharma R, Kumar A, Deedwania P
• Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.
  International journal of cardiology 2010 Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A
• Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study.
  European journal of heart failure 2010 Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, Aban I, Love TE, Deedwania P, Anker SD, Ahmed A
• Benefits of statin therapy and compliance in high risk cardiovascular patients.
  Vascular health and risk management 2010 Lardizabal JA, Deedwania PC
• Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus".
  Archives of internal medicine 2010 Deedwania PC
• Hypertension as a cardiometabolic risk.
  Indian heart journal 2010 Srikanth S, Deedwania P
• Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
  Journal of hypertension 2010 Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC
• Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).
  The American journal of cardiology 2010 Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A
• Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
  The American journal of cardiology 2010 Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD
• Effect of nateglinide on the incidence of diabetes and cardiovascular events.
  The New England journal of medicine 2010 NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania…
• Effect of valsartan on the incidence of diabetes and cardiovascular events.
  The New England journal of medicine 2010 NAVIGATOR Study Group, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania…
• Atrial fibrillation in heart failure: a comprehensive review.
  The American journal of medicine 2010 Deedwania PC, Lardizabal JA
• The current state of beta blockers in hypertension therapy.
  Indian heart journal 2010 Lardizabal JA, Deedwania PC
• New York Heart Association functional class influences the impact of diabetes on cardiac autonomic function.
  Journal of electrocardiology 2010 Stein PK, Deedwania P
• Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial).
  The American journal of cardiology 2009 LaRosa JC, Deedwania PC, Shepherd J, Wenger NK, Greten H, DeMicco DA, Breazna A, TNT Investigators
• Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
  Diabetic medicine : a journal of the British Diabetic Association 2009 Bethel MA, Deedwania P, Levitt NS, Schmitz O, Huntsman-Labed A, Califf RM, Haffner SM, Diem P, NAVIGATOR Study Group
• Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
  Vascular health and risk management 2009 Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC
• Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
  The American journal of cardiology 2009 Deedwania P, Singh V, Davidson MH
• An overview of glycemic control in the coronary care unit with recommendations for clinical management.
  Journal of diabetes science and technology 2009 Kosiborod M, Deedwania P
• Beta-adrenergic blockers for chronic heart failure.
  Cardiology in review 2009 Javed U, Deedwania PC
• Reducing morbidity and mortality in high risk patients with statins.
  Vascular health and risk management 2009 Singh V, Deedwania P
• Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study).
  The American journal of cardiology 2009 Stein PK, Deedwania P
• Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial.
  Journal of the American Society of Hypertension : JASH 2009 Fonarow GC, Deedwania P, Fonseca V, Nesto RW, Watson K, Tarka E, Lukas MA, Madan A, Shabbout M
• Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
  Journal of the American College of Cardiology 2009 Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, …
• Contemporary approaches for cardiovascular risk reduction in diabetes.
  Indian heart journal 2009 Deedwania P
• Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state.
  Reviews in cardiovascular medicine 2009 Deedwania PC, Carbajal EV
• Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
  Circulation 2008 Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, …
• Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
  Diabetes care 2008 Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, …
• Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
  Journal of clinical hypertension (Greenwich, Conn.) 2008 Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA
• Angiotensin receptor blockers: novel role in high-risk patients.
  Cardiology clinics 2008 Javed U, Deedwania PC
• Statins in heart failure.
  Cardiology clinics 2008 Deedwania PC, Javed U
• Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
  American heart journal 2008 Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Dai D, Hernandez A, Fonarow GC
• The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism.
  International journal of cardiology 2008 Deedwania P
• Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
  The American journal of cardiology 2008 Ram CV, Deedwania PC
• Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
  Mayo Clinic proceedings 2008 Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK, Treating to New Targets Steering Committee and Investigators
• Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
  Anesthesiology 2008 Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P
• Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study.
  Journal of cardiovascular electrophysiology 2008 Stein PK, Sanghavi D, Domitrovich PP, Mackey RA, Deedwania P
• Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
  Circulation 2008 Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, TNT Study Group, IDEAL Study …
• Expanding roles for atorvastatin.
  Drugs of today (Barcelona, Spain : 1998) 2008 Singh V, Deedwania P
• The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study.
  Journal of clinical hypertension (Greenwich, Conn.) 2008 Kostis JB, Breazna A, Deedwania PC, LaRosa JC, Treating to New Targets Steering Committee and Investigators
• Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
  Journal of the American College of Cardiology 2008 Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, TNT (Treating to New Targets) Investigators
• Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
  Circulation 2008 Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P, American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Me
• Diabetes and vascular disease.
  Expert review of cardiovascular therapy 2008 Deedwania P, Srikanth S
• Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies.
  Indian heart journal 2008 Gupta R, Gupta VP, Bhagat N, Rastogi P, Sarna M, Prakash H, Deedwania PC
• 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina.
  Journal of the American College of Cardiology 2007 Fraker TD, Fihn SD, 2002 Chronic Stable Angina Writing Committee, American College of Cardiology, American Heart Association, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, …
• 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina.
  Circulation 2007 Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Smith SC, Jacobs AK, …
• Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.
  Journal of clinical hypertension (Greenwich, Conn.) 2007 Deedwania P
• Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
  Clinical journal of the American Society of Nephrology : CJASN 2007 Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, Treating to New Targets Investigators
• Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
  Stroke 2007 Ford GA, Choy AM, Deedwania P, Karalis DG, Lindholm CJ, Pluta W, Frison L, Olsson SB, SPORTIF III, V Investigators
• Management of coronary artery disease in patients with type 2 diabetes mellitus.
  Current cardiology reports 2007 Srikanth S, Deedwania P
• Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).
  The American journal of cardiology 2007 Deedwania PC, Gupta M, Stein M, Ycas J, Gold A, IRIS Study Group
• Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.
  Circulation 2007 Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA
• Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
  Circulation 2007 Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck-Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D
• Clinical efficacy and cost-effectiveness of rosuvastatin.
  Expert review of pharmacoeconomics & outcomes research 2007 Deedwania PC, Smith DG
• Trials and tribulations associated with angina and traditional therapeutic approaches.
  Clinical cardiology 2007 Deedwania PC, Carbajal EV, Bobba VR
• Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
  Circulation 2007 Khush KK, Waters DD, Bittner V, Deedwania PC, Kastelein JJ, Lewis SJ, Wenger NK
• Diastolic dysfunction and autonomic abnormalities in patients with systolic heart failure.
  European journal of heart failure 2006 Stein PK, Tereshchenko L, Domitrovich PP, Kleiger RE, Perez A, Deedwania P
• Management issues in the metabolic syndrome.
  The Journal of the Association of Physicians of India 2006 Deedwania PC, Gupta R
• Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
  Lancet (London, England) 2006 Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD, Treating to New Targets Investigators
• Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.
  Journal of the renin-angiotensin-aldosterone system : JRAAS 2006 Deedwania PC, Schmieder R
• Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
  Diabetes care 2006 Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D
• Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
  The American journal of cardiology 2006 Pitt B, Fonarow GC, Gheorghiade M, Deedwania PC, Duprez DA
• Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
  Journal of the cardiometabolic syndrome 2006 Deedwania PC, Maki KC, Dicklin MR, Stone NJ, Ballantyne CM, Davidson MH
• Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics.
  Current atherosclerosis reports 2006 Singh V, Deedwania P
• Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
  Journal of cardiac failure 2005 Caro JJ, Migliaccio-Walle K, O'Brien JA, Nova W, Kim J, Hauch O, Hillson E, Wedel H, Hjalmarson A, Gottlieb S, Deedwania PC, Wikstrand J, MERIT-HF Study Group
• Coronary artery disease in South Asians: evolving strategies for treatment and prevention.
  Indian heart journal 2005 Deedwania P, Singh V
• Avoid the rush to judgment in acute coronary syndromes.
  Postgraduate medicine 2005 Deedwania P
• Bedside evaluation of cardiac markers. Point-of-care testing can differentiate acute coronary syndromes.
  Postgraduate medicine 2005 Amsterdam EA, Deedwania P
• Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
  The American journal of medicine 2005 Deedwania PC, Fonseca VA
• Treating non-ST-segment elevation ACS. Pros and cons of current strategies.
  Postgraduate medicine 2005 Carbajal EV, Deedwania P
• Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
  The American journal of cardiology 2005 Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM
• Intensive lipid-lowering is no more effective than diet and low-dose lovastatin for reducing ischaemia in people with heart disease. Commentary.
  Evidence-based cardiovascular medicine 2005 Deedwania P
• Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach.
  Cardiology clinics 2005 Srikanth S, Deedwania P
• Current Treatment Options for the Metabolic Syndrome.
  Current treatment options in cardiovascular medicine 2005 Deedwania PC, Volkova N
• Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
  Cardiology clinics 2005 Deedwania PC
• Dyslipidemia and lipid-lowering therapy in the elderly.
  Expert review of cardiovascular therapy 2005 Deedwania P, Volkova N
• The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.
  Cardiology clinics 2005 Vijayaraghavan K, Deedwania PC
• Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
  The American journal of cardiology 2005 Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto JW, STELLAR Study Group
• What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
  Journal of the American College of Cardiology 2005 Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J, MERIT-HF Study Group
• Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
  American heart journal 2005 Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J, MERIT-HF Study Group
• Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
  Journal of cardiac failure 2004 Ghali JK, Dunselman P, Waagstein F, Goldstein S, Gottlieb SS, Deedwania PC, Wikstrand JC
• Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
  American heart journal 2004 Deedwania PC, Study Assessing Goals in the Elderly steering committee and investigators
• Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
  Cardiology clinics 2004 Deedwania PC
• Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.
  Cardiology clinics 2004 Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC
• Prevalence of metabolic syndrome in an Indian urban population.
  International journal of cardiology 2004 Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K
• Treating dyslipidemia in high-risk patients: case reviews and discussion.
  Postgraduate medicine 2004 Deedwania PC, Davidson MH, Ballantyne CM
• Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.
  European heart journal 2004 Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JC, MERIT-HF Study Group
• Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome.
  The American journal of cardiology 2004 Deedwania PC, Hunninghake DB, Bays H
• Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?
  Circulation 2004 Deedwania PC
• A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.
  Journal of cardiac failure 2003 Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E, BEST Investigators
• The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.
  Journal of the American College of Cardiology 2003 Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR, BEST Investigators
• How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
  Cardiac electrophysiology review 2003 Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F
• Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure).
  The American journal of cardiology 2003 Goldstein S, Deedwania P, Gottlieb S, Wikstrand J, MERIT-HF Study Group
• Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population.
  Journal of human hypertension 2003 Gupta R, Sharma AK, Gupta VP, Bhatnagar S, Rastogi S, Deedwania PC
• Mechanisms of endothelial dysfunction in the metabolic syndrome.
  Current diabetes reports 2003 Deedwania PC
• The rational use of diuretics in heart failure.
  Current cardiology reports 2003 Ravnan SL, Deedwania PC
• The key to unraveling the mystery of mortality in heart failure: an integrated approach.
  Circulation 2003 Deedwania PC
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
  Circulation 2003 Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF…
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).
  Journal of the American College of Cardiology 2003 Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, American College of Cardiology, American …
• Diabetes and vascular disease: common links in the emerging epidemic of coronary artery disease.
  The American journal of cardiology 2003 Deedwania PC
• Heart failure in the elderly: is beta-blockade the standard of care?
  Postgraduate medicine 2002 Deedwania PC
• Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS).
  American heart journal 2002 Matalka MS, Ravnan MC, Deedwania PC
• Prevention of and medical therapy for atrial arrhythmias in heart failure.
  Heart failure reviews 2002 Khand AU, Cleland JG, Deedwania PC
• Treating hypertension in patients with diabetes.
  The Nurse practitioner 2002 Reynolds HQ, Deedwania PC
• Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory.
  Journal of the American College of Cardiology 2002 Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ, Veterans Affairs Non-Q-Wave Infarction Stategies in-Hospital (VANQWISH) Trial Investigators
• Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
  Circulation 2002 Ghali JK, Piña IL, Gottlieb SS, Deedwania PC, Wikstrand JC, MERIT-HF Study Group
• Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).
  American heart journal 2002 Spertus JA, Tooley J, Jones P, Poston C, Mahoney E, Deedwania P, Hurley S, Pitt B, Weintraub WS
• Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
  Circulation 2002 Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J, MERIT-HF Investigators
• The changing face of hypertension: is systolic blood pressure the final answer?
  Archives of internal medicine 2002 Deedwania PC
• Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure.
  Congestive heart failure (Greenwich, Conn.) 2002 Ravnan SL, Ravnan MC, Deedwania PC
• Clinical significance of cardiovascular dysmetabolic syndrome.
  Current controlled trials in cardiovascular medicine 2002 Deedwania PC
• Ambulatory electrocardiographic monitoring for myocardial ischemia.
  Current problems in cardiology 2001 Deedwania PC, Stone PH
• Pharmacotherapy of hypertension in patients with diabetes mellitus.
  Expert opinion on pharmacotherapy 2001 Deedwania PC
• Global risk assessment in the presymptomatic patient.
  The American journal of cardiology 2001 Deedwania P
• Fractal and complexity measures of heart rate dynamics after acute myocardial infarction.
  The American journal of cardiology 2001 Perkiömäki JS, Zareba W, Ruta J, Dubner S, Madoery C, Deedwania P, Karcz M, Bayes de Luna A, IDEAL Investigators
• Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
  American heart journal 2001 Wedel H, Demets D, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J, MERIT-HF Study Group
• Silent ischemia predicts poor outcome in high-risk healthy men.
  Journal of the American College of Cardiology 2001 Deedwania PC
• Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
  Journal of cardiovascular pharmacology and therapeutics 2001 Sun YP, Zhu BQ, Browne AE, Pulukurthy S, Chou TM, Sudhir K, Glantz SA, Deedwania PC, Chatterjee K, Parmley WW
• Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
  JAMA 2001 Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB, VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein …
• Atrial fibrillation in patients with heart failure: pharmacologic options.
  Congestive heart failure (Greenwich, Conn.) 2001 Matalka MS, Deedwania PC
• Coronary heart disease and risk factors in Asian Indians.
  Advances in experimental medicine and biology 2001 Chandalia M, Deedwania PC
• Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction; results of Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) trial.
  European heart journal 2000 Heggunje PS, Wade MJ, O'Rourke RA, Kleiger RE, Deedwania PC, Lavori PW, Boden WE, VANQWISH trial investigators
• Mechanism of the deadly quartet.
  The Canadian journal of cardiology 2000 Deedwania PC
• Hypertension and diabetes: new therapeutic options.
  Archives of internal medicine 2000 Deedwania PC
• Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
  Geriatrics 2000 Deedwania PC
• Silent myocardial ischaemia in the elderly.
  Drugs & aging 2000 Deedwania PC
• Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
  JAMA 2000 Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PH, …
• Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change.
  Journal of cardiac failure 2000 Wong M, Germanson T, Taylor WR, Cohen IS, Perry G, Baruch L, Deedwania P, Lopez B, Cohn JN
• Endothelium: a new target for cardiovascular therapeutics.
  Journal of the American College of Cardiology 2000 Deedwania PC
• ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.
  Journal of the American College of Cardiology 1999 Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A, Green LA, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, …
• Pharmacotherapy in congestive heart failure: Do NSAIDs attenuate the therapeutic effect of ACE inhibitors in heart failure patients?
  Congestive heart failure (Greenwich, Conn.) 1999 Matalka MS, Deedwania PC
• ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography).
  Circulation 1999 Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A, Green LA, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, …
• Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke.
  Hypertension (Dallas, Tex. : 1979) 1999 Hutchison SJ, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Cooke JP, Glantz SA, Parmley WW
• Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.
  Heart disease (Hagerstown, Md.) 1999 Gradman AH, Lewin A, Bowling BT, Tonkon M, Deedwania PC, Kezer AE, Hardison JD, Cushing DJ, Michelson EL
• Anti-ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group.
  The American journal of cardiology 1999 Deedwania PC
• Endothelin, the bad actor in the play: a marker or mediator of cardiovascular disease.
  Journal of the American College of Cardiology 1999 Deedwania PC
• Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
  The American journal of cardiology 1999 Frishman WH, Glasser S, Stone P, Deedwania PC, Johnson M, Fakouhi TD
• Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.
  Circulation 1998 Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN
• How do we best treat patients with ischemic heart disease?
  Circulation 1998 Pepine CJ, Deedwania PC
• In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats.
  Journal of the American College of Cardiology 1998 Hutchison SJ, Glantz SA, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Parmley WW, Sudhir K
• Tophaceous pseudogout of the mitral valve.
  The Annals of thoracic surgery 1998 Moon MR, Fann JI, Deedwania PC, Ferguson R, Kosek JC, Burdon TA
• A perspective on hyperlipidemia: concepts of management in the prevention of coronary artery disease.
  The American journal of medicine 1998 Amsterdam EA, Deedwania PC
• The American College of Physicians guidelines for screening blood cholesterol levels: a commentary.
  The American journal of medicine 1998 Criqui MH, Kinosian B, Glick H, Deedwania PC, Krauss RM
• The cardiovascular dysmetabolic syndrome.
  The American journal of medicine 1998 Fagan TC, Deedwania PC
• The deadly quartet revisited.
  The American journal of medicine 1998 Deedwania PC
• Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.
  The New England journal of medicine 1998 Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW
• Antioxidant diet preserves endothelium-dependent vasodilatation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke.
  Journal of cardiovascular pharmacology 1998 Schwarzacher SP, Hutchison S, Chou TM, Sun YP, Zhu BQ, Chatterjee K, Glantz SA, Deedwania PC, Parmley WW, Sudhir K
• Effects of antioxidant vitamins C and E on atherosclerosis in lipid-fed rabbits.
  Cardiology 1998 Sun YP, Zhu BQ, Sievers RE, Norkus EP, Parmley WW, Deedwania PC
• Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators.
  Journal of the American College of Cardiology 1998 Ferry DR, O'Rourke RA, Blaustein AS, Crawford MH, Deedwania PC, Carson PE, Pepine CJ, Thomas RG, Hlatky MA, Leppo JA, Iwane MK, Kleiger RE, Zoble RG, Dai H, Chow BK, Lavori PW, Boden WE
• Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period.
  Journal of the American College of Cardiology 1997 Zhu BQ, Sun YP, Sudhir K, Sievers RE, Browne AE, Gao L, Hutchison SJ, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW
• Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve.
  Archives of internal medicine 1997 Deedwania PC
• Role of beta blockade in the treatment of myocardial ischemia.
  The American journal of cardiology 1997 Deedwania PC, Carbajal EV
• Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants.
  Circulation 1997 Muller JE, Kaufmann PG, Luepker RV, Weisfeldt ML, Deedwania PC, Willerson JT
• The progression from hypertension to heart failure.
  American journal of hypertension 1997 Deedwania PC
• Lipoprotein(a) in patients who have non-insulin-dependent diabetes with and without coronary artery disease.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 1997 Ginier P, Deedwania P
• Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
  The American journal of cardiology 1997 Deedwania PC, Pool PE, Thadani U, Eff J
• Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320).
  Journal of the American College of Cardiology 1997 Singh SN, Fisher SG, Deedwania PC, Rohatgi P, Singh BN, Fletcher RD
• Can ambulatory monitoring identify high-risk patients with stable coronary artery disease?
  JAMA 1997 Deedwania PC, Carbajal EV
• Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits.
  Hypertension (Dallas, Tex. : 1979) 1997 Hutchison SJ, Reitz MS, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW
• Clinical relevance of ischemia induced by mental stress.
  Clinical cardiology 1997 Deedwania PC
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Lancet (London, England) 1997 Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI
• Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta.
  Journal of the American College of Cardiology 1997 Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K
• Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management.
  Archives of internal medicine 1997 Deedwania PC, Amsterdam EA, Vagelos RH
• Silent ischaemia: to treat or not to treat?
  Indian heart journal 1996 Deedwania PC
• Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.
  Circulation 1996 Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN
• Hemodynamic changes as triggers of cardiovascular events.
  Cardiology clinics 1996 Deedwania PC
• Anti-ischemic properties of ACE-inhibitors.
  Cardiologia (Rome, Italy) 1996 Deedwania PC
• Hemodynamic variability and myocardial ischemia.
  Cardiology clinics 1995 Deedwania PC
• Clinical perspectives on primary and secondary prevention of coronary atherosclerosis.
  The Medical clinics of North America 1995 Deedwania PC
• Contemporary approaches in medical management of patients with stable coronary artery disease.
  The Medical clinics of North America 1995 Carbajal EV, Deedwania PC
• Early intervention in patients with heart failure and left ventricular dysfunction.
  The Medical clinics of North America 1995 Deedwania PC
• Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
  The New England journal of medicine 1995 Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D
• Mental stress, pain perception and risk of silent ischemia.
  Journal of the American College of Cardiology 1995 Deedwania PC
• Randomized Placebo-Controlled Withdrawal Study of Amlodipine in Agina Pectoris.
  American journal of therapeutics 1995 Gorwit J, Haidet GC, Russell DC, Tonkon M, Deedwania PC, Borer JS
• The need for a cost-effective strategy to detect ambulatory silent ischemia.
  The American journal of cardiology 1994 Deedwania PC
• Triggers and timing of coronary events and sudden cardiac death.
  Journal of the American College of Cardiology 1994 Deedwania PC
• Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
  Circulation 1994 Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U
• Is there evidence in support of the ischemia suppression hypothesis?
  Journal of the American College of Cardiology 1994 Deedwania PC
• Should asymptomatic subjects with silent ischemia undergo further evaluation and follow-up?
  International journal of cardiology 1994 Deedwania PC
• Comparison of the prognostic values of ischemia during daily life and ischemia induced by treadmill exercise testing.
  The American journal of cardiology 1994 Deedwania PC
• Predictors of mortality in patients with heart failure.
  Cardiology clinics 1994 Gradman AH, Deedwania PC
• Prevalence and prognosis of heart failure.
  Cardiology clinics 1994 Deedwania PC
• Prevention of heart failure and postinfarction remodeling.
  Cardiology clinics 1994 Deedwania PC
• Ventricular arrhythmias in heart failure: to treat or not to treat?
  Cardiology clinics 1994 Deedwania PC
• Does myocardial ischemia portend poor prognosis?
  Journal of the American College of Cardiology 1994 Deedwania PC
• Information integration in a decision support system.
  Proceedings. Symposium on Computer Applications in Medical Care 1994 Hudson DL, Cohen ME, Deedwania PC
• Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators.
  The American journal of cardiology 1993 Singh SN, Fletcher RD, Fisher S, Lazzeri D, Deedwania P, Lewis D, Massie B, Singh BN, Colling C
• Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
  Clinical cardiology 1993 Deedwania PC, Cheitlin MD, Das SK, Pool PE, Singh JB, Pasternak RC
• Increased demand versus reduced supply and the circadian variations in ambulatory myocardial ischemia. Therapeutic implications.
  Circulation 1993 Deedwania PC
• Asymptomatic ischemia during predischarge Holter monitoring predicts poor prognosis in the postinfarction period.
  The American journal of cardiology 1993 Deedwania PC
• Secondary prevention after myocardial infarction. Too many choices, which ones work?
  Archives of internal medicine 1993 Deedwania PC, Carbajal EV
• Diagnostic and therapeutic implications: exploration through case discussions.
  The American journal of cardiology 1992 Jaffe AS, Deedwania PC, Higginson LA, Boden WE, Mehta JL, Ferlinz J, Walsh RA, Sullivan JM, Vokonas PS, Cabin H
• Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life.
  The American journal of cardiology 1992 Deedwania PC, Carbajal EV
• The Council for Myocardial Ischemia and Infarction: advisory group reports on silent myocardial ischemia, heart rate control, and post-myocardial infarction management.
  The American journal of cardiology 1992 Deedwania PC, Schroeder JS, Boden WE
• Increased myocardial oxygen demand and ischemia during daily life: resurrection of an age-old concept.
  Journal of the American College of Cardiology 1992 Deedwania PC
• Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators.
  Controlled clinical trials 1992 Singh S, Fletcher RD, Fisher S, Deedwania P, Lewis D, Massie B, Singh B, Colling CL
• Ambulatory electrocardiography evaluation of asymptomatic, unstable, and stable coronary artery disease patients for myocardial ischemia.
  Cardiology clinics 1992 Deedwania PC, Carbajal EV
• Systemic and coronary hemodynamic effects of bepridil in patients with depressed left ventricular function.
  The American journal of cardiology 1992 De Marco T, Deedwania P, Chatterjee K
• Silent myocardial ischemia. A clinical perspective.
  Archives of internal medicine 1991 Deedwania PC, Carbajal EV
• Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia.
  The American journal of cardiology 1991 Deedwania PC, Carbajal EV
• The prognostic and economic implications of a strategy to detect and treat asymptomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol.
  Clinical cardiology 1991 Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Gottlieb SO, Handberg E, Hill JA
• Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.
  Journal of the American College of Cardiology 1991 Deedwania PC, Carbajal EV, Nelson JR, Hait H
• Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris.
  The American journal of cardiology 1990 Deedwania PC, Carbajal EV
• Transient myocardial ischemia and its relation to determinants of myocardial oxygen demand.
  The American journal of cardiology 1990 Deedwania PC
• Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring.
  Circulation 1990 Deedwania PC, Nelson JR
• Angiotensin-converting enzyme inhibitors in congestive heart failure.
  Archives of internal medicine 1990 Deedwania PC
• Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy.
  The American journal of cardiology 1990 Deedwania PC, Carbajal EV
• Silent ischemia during daily life is an independent predictor of mortality in stable angina.
  Circulation 1990 Deedwania PC, Carbajal EV
• Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes.
  The American journal of cardiology 1990 Deedwania PC
• Is silent myocardial ischemia clinically important? Does it have prognostic significance?
  Postgraduate medicine 1989 Deedwania PC, Carbajal EV
• Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina.
  American heart journal 1989 Deedwania P, Cheitlin M, Das S, Pool P, Singh J, Pasternak R, Carabello B
• Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.
  Journal of the American College of Cardiology 1989 Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S
• New exercise parameter for the identification of severe coronary artery disease.
  Chest 1989 Nelson JR, Deedwania PC
• Effects of beta-adrenergic stimulation on atrial latency and atrial vulnerability in patients with paroxysmal supraventricular tachycardia.
  The American journal of cardiology 1988 Nguyen NX, Yang PT, Huycke EC, Keung EC, Deedwania P, Sung RJ
• Electrophysiologic studies in cardiac arrhythmia. When and why they are useful.
  Postgraduate medicine 1988 Nallasivan M, Deedwania PC
• Significance of arrhythmias in congestive heart failure.
  Postgraduate medicine 1988 Deedwania PC
• Similar efficacy of nitrendipine in young and elderly hypertensive patients.
  The American journal of cardiology 1987 Mehta J, Lopez LM, Deedwania PC, Fagan TC, Sternlieb CM, Vlachakis ND, Birkett JP, Schwartz LA
• Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
  Drugs 1987 Singh BN, Deedwania P, Nademanee K, Ward A, Sorkin EM
• Beta blockers in combination with class I antiarrhythmic agents.
  The American journal of cardiology 1987 Deedwania PC, Olukotun AY, Kupersmith J, Jenkins P, Golden P
• Current perspectives in treatment of angina pectoris.
  Postgraduate medicine 1986 Deedwania PC, Carbajal EV
• Silent myocardial ischemia and its relationship to acute myocardial infarction.
  Cardiology clinics 1986 Deedwania PC
• Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
  Journal of cardiovascular pharmacology 1984 Fagan TC, Sternleib C, Vlachakis N, Deedwania PC, Mehta JL
• Calcium channel blockers.
  The Western journal of medicine 1982 Deedwania PC
• Effect of age on atrioventricular conduction in patients with chronic bifascicular block.
  The American journal of cardiology 1980 Dhingra RC, Wyndham C, Deedwania PC, Bauernfeind R, Swiryn S, Best D, Rosen KM
• Chronic intraventricular conduction defects.
  Indian heart journal: teaching series 1980 Deedwania PC, Dhingra RC
• Significance of fascicular block complicating acute myocardial infarction.
  Indian heart journal: teaching series 1980 Dhingra RC, Deedwania PC
• Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block.
  Circulation 1979 Dhingra RC, Wyndham C, Bauernfeind R, Swiryn S, Deedwania PC, Smith T, Denes P, Rosen KM
• Nocturnal atrioventricular block as a manifestation of sleep apnea syndrome.
  Chest 1979 Deedwania PC, Swiryn S, Dhingra RC, Rosen KM
• Electrophysiologic observations in a patient with bradycardia-dependent atrioventricular block.
  The American journal of cardiology 1978 Wu D, Deedwania P, Dhingra RC, Engleman RM, Rosen KM
• Electrophysiologic effects of lidocaine on sinus node and atrium in patients with and without sinoatrial dysfunction.
  Circulation 1978 Dhingra RC, Deedwania PC, Cummings JM, Amat-Y-Leon F, Wu D, Denes P, Rosen KM
• Sites of conduction disease in aortic stenosis: significance of valve gradient and calcification.
  Annals of internal medicine 1977 Dhingra RC, Amat-y-Leon F, Pietras RJ, Wyndham C, Deedwania PC, Wu D, Denes P, Rosen KM
• A new approach for indirect recording of anterior left atrial activation in man.
  American heart journal 1977 Amat-y-Leon F, Deedwania P, Miller RH, Dhingra RC, Rosen KM
• Clinical significance of prolonged sinoatrial conduction time.
  Circulation 1977 Dhingra RC, Amat-y-Leon F, Wyndham C, Deedwania PC, Wu D, Denes P, Rosen KM